RankAlpha logo
Back to Rankings

IBRX

ImmunityBioC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
IBRX vs peer average
58/100
IBRX vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 2 · D 4 · F 2
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

AUPH is the first available peer comparator.

Closest size-matched commercial biopharma comparator in the packet; useful for judging whether IBRX can convert a single marketed specialty asset into durable revenue and narrower financing risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAUPHAurinia
IBRX
ImmunityBio
AUPH
Aurinia
Grade
C
B
Momentum
86
45
Value
41
69
Sentiment
57
66
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive

Grade position vs AUPH

IBRX / AUPH
Grade Position
In line
IBRX vs. peer average (C vs. C)
58/100
Momentum
86
IBRX
Value
41
AUPH
Sentiment
57
AUPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IBRX
1
AUPH
AUPH
B
80/100
-1
2
GLPG
GLPG
-
-
-
3
REGN
REGN
C
60/100
Even
4
ALKS
Alkermes plc Common
A
100/100
-2
5
TWST
Twist Bioscience Corp Common
F
20/100
+2
AUPH is the first peer returned for this comparison set.